1 Three or more lines visual acuity lost at 6 months |
5 |
503 |
Risk Ratio (M‐H, Random, 95% CI) |
0.75 [0.55, 1.03] |
2 Three or more lines visual acuity lost at 12 months |
8 |
759 |
Risk Ratio (M‐H, Random, 95% CI) |
0.90 [0.74, 1.10] |
3 Three or more lines visual acuity lost at 24 months |
4 |
428 |
Risk Ratio (M‐H, Random, 95% CI) |
0.81 [0.63, 1.03] |
4 Six or more lines visual acuity lost at 6 months |
5 |
502 |
Risk Ratio (M‐H, Random, 95% CI) |
0.41 [0.18, 0.94] |
5 Six or more lines visual acuity lost at 12 months |
7 |
576 |
Risk Ratio (M‐H, Random, 95% CI) |
0.62 [0.44, 0.87] |
6 Six or more lines visual acuity lost at 24 months |
4 |
428 |
Risk Ratio (M‐H, Random, 95% CI) |
0.81 [0.64, 1.03] |
7 Mean and change in visual acuity at 12 months |
10 |
|
Mean Difference (Random, 95% CI) |
‐0.10 [‐0.16, ‐0.04] |
7.1 Mean visual acuity |
5 |
|
Mean Difference (Random, 95% CI) |
‐0.16 [‐0.30, ‐0.02] |
7.2 Change in visual acuity |
5 |
|
Mean Difference (Random, 95% CI) |
‐0.08 [‐0.14, ‐0.01] |
8 Investigating heterogeneity: type of CNV |
8 |
759 |
Odds Ratio (M‐H, Fixed, 95% CI) |
0.81 [0.61, 1.09] |
8.1 Classic < 50% |
5 |
426 |
Odds Ratio (M‐H, Fixed, 95% CI) |
0.91 [0.62, 1.34] |
8.2 Classic 50%+ |
3 |
333 |
Odds Ratio (M‐H, Fixed, 95% CI) |
0.70 [0.45, 1.10] |
9 Investigating heterogeneity: dosage |
8 |
759 |
Odds Ratio (M‐H, Fixed, 95% CI) |
0.81 [0.61, 1.09] |
9.1 > 14 Gy |
3 |
308 |
Odds Ratio (M‐H, Fixed, 95% CI) |
0.80 [0.50, 1.25] |
9.2 <= 14 Gy |
5 |
451 |
Odds Ratio (M‐H, Fixed, 95% CI) |
0.83 [0.56, 1.21] |
10 Investigating heterogeneity: sham irradiation in control group |
8 |
759 |
Odds Ratio (M‐H, Fixed, 95% CI) |
0.81 [0.61, 1.09] |
10.1 Control group observation only |
5 |
419 |
Odds Ratio (M‐H, Fixed, 95% CI) |
0.73 [0.49, 1.07] |
10.2 Control group sham irradiation |
3 |
340 |
Odds Ratio (M‐H, Fixed, 95% CI) |
0.95 [0.60, 1.48] |